Eldon C. Mayer, III

2017

In 2017, Eldon C. Mayer, III earned a total compensation of $712K as Executive Vice President, Chief Commercial Officer at Rigel Pharmaceuticals, a 37% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$192,500
Option Awards$131,182
Salary$385,000
Other$3,354
Total$712,035

Mayer received $385K in salary, accounting for 54% of the total pay in 2017.

Mayer also received $192.5K in non-equity incentive plan, $131.2K in option awards and $3.4K in other compensation.

Rankings

In 2017, Eldon C. Mayer, III's compensation ranked 10,529th out of 14,666 executives tracked by ExecPay. In other words, Mayer earned more than 28.2% of executives.

ClassificationRankingPercentile
All
10,529
out of 14,666
28th
Division
Manufacturing
4,092
out of 5,772
29th
Major group
Chemicals And Allied Products
1,454
out of 2,075
30th
Industry group
Drugs
1,185
out of 1,731
32nd
Industry
Pharmaceutical Preparations
923
out of 1,333
31st
Source: SEC filing on April 4, 2018.

Mayer's colleagues

We found five more compensation records of executives who worked with Eldon C. Mayer, III at Rigel Pharmaceuticals in 2017.

2017

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2017

Dolly Vance

Rigel Pharmaceuticals

General Counsel

2017

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

2017

Anne-Marie Duliege

Rigel Pharmaceuticals

Chief Medical Officer

2017

Esteban Masuda

Rigel Pharmaceuticals

Executive Vice President, Research

News

You may also like